CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy

The 16th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s largest meeting series of its kind, took place in Mainz, Germany from 15–17 May, 2018. Cutting-edge advancements in cancer immunotherapy were discussed among more than 700 scientists under the motto “Pushing Frontie...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Jan, Birtel, Matthias, Reidenbach, Daniel, Salomon, Nadja, Diken, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343606/
https://www.ncbi.nlm.nih.gov/pubmed/30111232
http://dx.doi.org/10.1080/21645515.2018.1504526
_version_ 1783389313026752512
author Beck, Jan
Birtel, Matthias
Reidenbach, Daniel
Salomon, Nadja
Diken, Mustafa
author_facet Beck, Jan
Birtel, Matthias
Reidenbach, Daniel
Salomon, Nadja
Diken, Mustafa
author_sort Beck, Jan
collection PubMed
description The 16th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s largest meeting series of its kind, took place in Mainz, Germany from 15–17 May, 2018. Cutting-edge advancements in cancer immunotherapy were discussed among more than 700 scientists under the motto “Pushing Frontiers in Cancer Immunotherapy”. This meeting report is a summary of some of the CIMT 2018 highlights.
format Online
Article
Text
id pubmed-6343606
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-63436062019-02-01 CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy Beck, Jan Birtel, Matthias Reidenbach, Daniel Salomon, Nadja Diken, Mustafa Hum Vaccin Immunother Meeting Report The 16th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s largest meeting series of its kind, took place in Mainz, Germany from 15–17 May, 2018. Cutting-edge advancements in cancer immunotherapy were discussed among more than 700 scientists under the motto “Pushing Frontiers in Cancer Immunotherapy”. This meeting report is a summary of some of the CIMT 2018 highlights. Taylor & Francis 2018-08-29 /pmc/articles/PMC6343606/ /pubmed/30111232 http://dx.doi.org/10.1080/21645515.2018.1504526 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Meeting Report
Beck, Jan
Birtel, Matthias
Reidenbach, Daniel
Salomon, Nadja
Diken, Mustafa
CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title_full CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title_fullStr CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title_full_unstemmed CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title_short CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16(th) Annual Meeting of the Association for Cancer Immunotherapy
title_sort cimt 2018: pushing frontiers in cancer immunotherapy — report on the 16(th) annual meeting of the association for cancer immunotherapy
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343606/
https://www.ncbi.nlm.nih.gov/pubmed/30111232
http://dx.doi.org/10.1080/21645515.2018.1504526
work_keys_str_mv AT beckjan cimt2018pushingfrontiersincancerimmunotherapyreportonthe16thannualmeetingoftheassociationforcancerimmunotherapy
AT birtelmatthias cimt2018pushingfrontiersincancerimmunotherapyreportonthe16thannualmeetingoftheassociationforcancerimmunotherapy
AT reidenbachdaniel cimt2018pushingfrontiersincancerimmunotherapyreportonthe16thannualmeetingoftheassociationforcancerimmunotherapy
AT salomonnadja cimt2018pushingfrontiersincancerimmunotherapyreportonthe16thannualmeetingoftheassociationforcancerimmunotherapy
AT dikenmustafa cimt2018pushingfrontiersincancerimmunotherapyreportonthe16thannualmeetingoftheassociationforcancerimmunotherapy

Ejemplares similares